Cemtrex reported a 22% year-over-year revenue increase to $22.7 million in Q4 2026, with operating income of $1.4 million, reversing prior losses. The Security segment led growth, showing a strong turnaround from losses earlier in the year. Fiscal 2026 revenue was $75.3 million, slightly down from 2025 due to a large one-time sale in the prior year. The company completed three acquisitions in 2026 and expects further growth from an additional pending acquisition in Industrial Services.
Cemtrex's Q4 and fiscal 2026 results provide context for industrial sector performance. For readers following Industrials, here is Pluang's market snapshot as of Oct 29, 2026 17:53 WIB: 76 of 135 US industrial stocks rose today, while 57 fell. Notable movers include FLS at USD 74.51 (+3.76%), HONA at USD 170.95 (-3.43%), and AOS at USD 58.98 (-3.09%).
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...
Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...
Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...
